AstraZeneca inks U.S. co-commercialization deal for OIC med
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 11:14AM CDT
AZN: 33.30 (+0.02), NKTR: 12.24 (+0.79)
FDA clears Daiichi-Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 6:55PM CST
PTLA: 49.77 (+3.03), PFE: 32.97 (+0.35), BMY: 59.22 (+0.47), JNJ: 92.93 (+0.21), ISIS: 54.08 (+1.07), MDCO: 43.05 (+0.95), BAX: 36.02 (-0.05), AZN: 33.30 (+0.02), MRK: 52.09 (-0.63), SCLN: 8.10 (+0.17), MSLI: 1.57 (-0.05)
ArQule prostate cancer drug candidate successful in Phase 2
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:19AM CST
ARQL: 1.71 (-0.01)
Ad Comm approaches for Daiichi Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:49PM CDT
The Next Biotech Buyout Stock
Motley Fool Staff - Motley Fool - Fri Oct 10, 7:15AM CDT
Biotech stocks are notoriously volatile, making them best suited for only the most risk-tolerant investors. But for those willing to take the risk, biotech companies can often make a big splash; particularly when a bigger fish gobbles them up....
JNJ: 92.93 (+0.21), PTLA: 49.77 (+3.03), PFE: 32.97 (+0.35), BMY: 59.22 (+0.47), PRTA: 59.97 (+2.34), PBYI: 103.28 (+6.59)